Nanocomposites-based targeted oral drug delivery systems with infliximab in a murine colitis model.
Kim JM, Kim DH, Park HJ, Ma HW, Park IS, Son M, Ro SY, Hong S, Han HK, Lim SJ, Kim SW, Cheon JH.
Kim JM, et al. Among authors: kim dh, kim sw.
J Nanobiotechnology. 2020 Sep 15;18(1):133. doi: 10.1186/s12951-020-00693-4.
J Nanobiotechnology. 2020.
PMID: 32933548
Free PMC article.